Navigation Links
Milestone Scientific Expands Domestic Sales Network With Addition of Three New Dental Distributors
Date:7/16/2008

Collectively, Benco Dental, Burkhart Dental and Goetze Dental Bring Over 300 Years Experience, 350 Sales Professionals and 35,000 Customers in Key

U.S. Regions

LIVINGSTON, N.J., July 16 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that leading independent dental supply companies -- Benco Dental, Burkhart Dental, Inc. and Goetze Dental -- have joined Milestone's growing domestic distribution network undertaking the sale and marketing of the STA(TM) System and related disposable products to dental practitioners across the U.S. and Canada.

The state-of-the-art STA System is Milestone's latest achievement in computer-controlled local anesthesia delivery (C-CLAD) that makes the injection process more comfortable for both dentists and patients. Marketed worldwide by Milestone's growing global distributor network to dental practitioners for the painless administration of all dental injections, the STA System is uniquely capable of predictably and more comfortably administering "Single Tooth Anesthesia" into the Periodontal Intraligamentary (PDL) space, something never before possible using conventional techniques.

Robert Presutti, Vice President, Sales and Marketing at Milestone, noted, "We are very proud that we have succeeded in winning the support of the U.S. dental supply industry's largest and most enduring companies. Armed with compelling market data and powerful testimonies from dentistry's most respected thought leaders, who agree that Milestone's STA System should become the new standard of care for administering anesthesia in dentistry, the combined reach and influence of Patterson Dental, Henry Schein and now Benco, Burkhart and Goetze, will help to promote greater market penetration and corresponding sales growth for our innovative injection technology."

Milestone is actively engaged in implementing a series of product and sales training programs with its new distributors' sales teams. In addition to coordinating a comprehensive training schedule with Benco, Burkhart and Goetze that is expected to continue through this fall, the Company is also involved with training sales reps at 87 Patterson Dental branch offices. In total, Milestone is now training and providing ongoing sales and marketing support to more than 2,300 distributor sales representatives serving the dental industry in the U.S. and Canada.

Benco Dental is a family-owned distributor of dental supplies. Its founder, Benjamin Cohen, began selling instruments to dentists in 1924 and formed Benco in 1930. Today, Benco is the largest independently owned dental supply company in the United States, and one of the nation's fastest growing dental distributors. With headquarters in Wilkes-Barre, Pennsylvania, Benco operates more than 40 regional showrooms. The Company is supplied by four distribution centers in Pennsylvania, Indiana, Texas and Florida. With sales territory encompassing 30 states in the eastern U.S., Benco Dental currently serves over 20,000 customers.

For over a century, Burkhart Dental has focused on helping dentists achieve both personal and professional success. Founded in 1888 by Dr. William E. Burkhart as the Tacoma Dental Depot, the Company has thrived and prospered as a family owned and managed dental supply company, led today by Dr. Burkhart's great, great granddaughter. Headquartered in Tacoma, Washington, Burkhart Dental serves over 5,000 customers in the western U.S. from its 18 office locations in Alaska, Colorado, Oregon, Arizona, California, Nevada, Texas, Utah, and Washington.

Originally established in 1884 as the St. Joseph Drug Company by founder W.F. Goetze, M.D., Goetze Dental has also endured as a family-owned and managed independent dental supplier for five generations. Headquartered in Kansas City, Missouri where it also operates a 45,000 square foot, state-of-the-art distribution facility, the Company also maintains branch showroom locations with fully stocked and staffed service departments in Denver, Des Moines, Omaha, Springfield, St. Louis and Wichita. Focusing primarily on the nine U.S. Midwestern state regions, Goetze Dental currently markets a broad range of leading dental products and services to a customer base of more than 10,000 dental professionals.

About Milestone Scientific Inc.

Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets. Central to the Company's IP platform and product development strategy is its patented CompuFlo(R) technology for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids. The STA(TM) (Single Tooth Anesthesia) System computer-controlled local anesthesia delivery system which uses this technology provides dentists with audible and visual signals as to in-tissue pressure. Milestone's existing painless injection systems are currently sold in 25 countries. For more information on these and other innovative Milestone products, please visit the Company's web site found at http://www.milesci.com.

Safe Harbor Statement

This press release contains forward-looking statements regarding the timing and financial impact of the Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report on Form 10-KSB for the year ended December 31, 2007. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

FOR MORE INFORMATION, PLEASE CONTACT:

Elite Financial Communications Group/Elite Media Group

Dodi Handy, President and CEO

407-585-1080 or via email at mlss@efcg.net


'/>"/>
SOURCE Milestone Scientific Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
2. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
3. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
4. Milestone Scientific to Exhibit the STA(TM) System at the American Dental Associations 148th Annual Session in San Francisco
5. Smurfit-Stones Hodge, LA, Mill Becomes First to Achieve Safety Milestone
6. Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization
7. Milestone Scientific to Present at the Edgewater Research Investor Conference
8. Isis Receives $1.25 Million Milestone Payment From iCo for Initiation of Phase 1 Study of iCo-007
9. Global Gene Map Clears New Milestone
10. Free Site Offering Patient-Physician Dialog Reaches Milestone
11. Marlo Thomas and St. Jude Childrens Research Hospital(R) Announce Hitting The 50-Partner Milestone as They Kick Off the Fourth Annual Thanks and Giving(R) Campaign Which Asks America to Support St. Jude While Shopping This Holiday Season
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... ... care communications company offering education, research and medical media, has launched ... working in infectious diseases. , As the all-inclusive resource for infectious disease ...
(Date:2/10/2016)... ... February 10, 2016 , ... MetLoop CEO Jay Southerland ... version at the International Roofing Expo in Orlando, Florida on February 17-19. , ... advanced weather technology in the hands of consumers, roofing contractors, manufacturers and distributors,” ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... and Video Remote Interpreting (VRI) within Healthcare, recently partnered with Heart City ... interpreting (VRI). , For nearly 23 years, Heart City Health Center has provided ...
(Date:2/10/2016)... Huntington, NY (PRWEB) , ... February 10, 2016 ... ... web-based compliance tracking solution, The Guard, to associations of medical professionals throughout the ... HIPAA compliance, including security risk assessments, policies and procedures, employee training, regulatory updates, ...
(Date:2/10/2016)... ... ... Emergency rooms provide emergency care to stabilize critical health issues, but emergency dental ... at risk of losing a tooth or their smiles. Dr. Marine Martirosyan, dentist ... include:, , Avulsed or knocked-out teeth , Dislodged ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... -- Resolve Therapeutics, LLC, a clinical stage biopharmaceutical company ... of lupus and Sjogrens syndrome, today announced the ... in patients with systemic lupus erythematosus (SLE) with ... --> Data from a multicenter ... RSLV-132 in 32 subjects with SLE demonstrate the ...
(Date:2/10/2016)... NEW YORK , Feb. 10, 2016 ... clinical-stage biopharmaceutical company, announced today that it has filed ... Myeloid Leukemia and other cancers. --> ... of treating cancer by administration of Ceplene (histamine dihydrochloride) ... also provides methods of predicting the efficacy of Ceplene ...
(Date:2/10/2016)... A Worldwide Clinical Trials expert will ... Victoria Park Plaza in London , 24-25 ... and future advances for late phase research on Wednesday, 24 ... , associate director of project management at Worldwide, will focus ... regulations and standards in late phase research. ...
Breaking Medicine Technology: